RELATED CONTENT
NEWS
- Merck Serono ditches cladribine, leaving MS franchise exposed
- Biogen seeks to retain lead in MS market with US BG-12 submission
- EMA guidance points up challenges to biosimilar interferon beta developers
- Start-up Nuron snags 1st licensing deal, with Mitsubishi, and advances PhIII MS drug
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

